Rifampicin-resistant Tuberculosis
📧 Sign up to get email alerts when something new happens for Rifampicin-resistant Tuberculosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Study of a Single Dose of Pretomanid Added to an Optimized Background Regimen in Children With Rifampicin-Resistant Tuberculosis [Phase 1]
A Phase 1 trial evaluating a single dose of pretomanid added to an optimized background regimen in children with rifampicin-resistant tuberc…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Acetohydroxamic Acid Combined With a Short-Course Regimen for MDR-TB (AHA-PLUS) [Phase 2]
This document reports a Phase 2 clinical trial (AHA-PLUS) evaluating acetohydroxamic acid in combination with a short-course regimen for mul…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets [Phase 2]
A Phase 2b clinical trial evaluating JDB0131 benzenesulfonate tablets for tuberculosis, including multidrug-resistant and rifampicin-resista…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BLMZ Chinese Cohort [Phase 3]
Phase 3 trial update evaluating a shorter, all-oral, precision treatment regimen for rifampicin-resistant tuberculosis in a Chinese cohort; …
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB) [Phase 3]
Phase 3 INSPIRE-TB trial evaluating an all-oral, shorter, individualized regimen for rifampicin-resistant tuberculosis, including multidrug-…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-04-01Clinical Trial Update: Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis：Contezolid, Delamanid and Bedaquiline Cohort [Phase 3]
Phase 3 trial update describing an all-oral, shorter, individualized regimen for rifampicin-resistant tuberculosis using contezolid, delaman…
-
CLINICAL_TRIALS research · 2024-08-22Clinical Trial Update: French National Cohort of Patients With Rifampicin-Resistant Tuberculosis
A clinical trial update for a French national cohort of patients with rifampicin-resistant tuberculosis; the study is not yet recruiting.